Microarrays have revolutionized molecular biology. The numbers of applications for microarrays are growing as quickly as their probe density. Paradoxically, microarray data still contains a large number of variables and a small number of replicates creating unique data analysis sets. The first and most important goal is to design microarray experiments that yield statistically defensible results. This generation of such useful data requires effective communication between those designing and running the experiments, with those analyzing the data, to those software and database developers who facilitate the data handling. CHI's Seventh Annual New Applications for Microarray Data Analysis: Integrating Genetics with “Omics” continues the tradition of providing perspectives from each specialty, with an emphasis on how they can be integrated into a cohesive, comprehensive team to better decipher biologic pathways and determine the total “omic” picture.

SCIENTIFIC ADVISORS:

Andrew Brooks, Rutgers University
Thomas J. Downey, Partek, Inc.
David L. Gerhold, Merck & Co., Inc.
Kenton D. Juhlin, Procter & Gamble
Jean Claude Zenklusen, National Cancer Institute

Highlighting Microarray Applications and Data Analysis for:

• Whole Genome Association

• Tiling Arrays

• SNPs

• Copy Number Analysis

• Alternative Splicing

• ChIP on Chip

Wednesday, August 15

Plus Pre-Conference Short Courses

Short Course One

• Optimizing Microarray Gene Expression Data:
  Insights, Experiences, and Results

Short Course Two

• Statistical Analysis for the New Microarray
  Applications

Speakers:

John Castle, Roselta Inpharmatics
Shannon Conners, SAS Institute
Thomas J. Downey, Partek, Inc.
David J. Edwards, Stratagene
David E. Fisher, Dana Farber Cancer Institute (invited)
Erin Heinzen, Duke University
Paul Hodor, Merck & Co., Inc.
Rui-Ru Ji, Bristol-Myers Squibb
Jae Lee, University of Virginia
Richard Lempicki, SAIC-Frederick, NIAID/NIH
Dan Li, Ph.D., Eli Lilly and Company
Leping Li, NIEHS/NIH
Wei Liu, Wyeth Research
Elizabeth Mansfield, OIVD/CDRH/FDA
Dalila Pinto, The Hospital for Sick Children, Toronto
Constantin Polychronakos, McGill University Health Center
Nandini Raghavan, Johnson & Johnson Pharmaceutical Research & Development LLC
Frederic Raymond, Nestle Research Center
Hugues Sicotte, Mayo Foundation
Michael Tainsky, Wayne State University School of Medicine
Joëlle Tchinda, Brigham and Women's Hospital
George Uhl, NIDA/NIH
Beth Wilmot, Oregon Health & Science University
Ming Yi, SAIC-Frederick, Inc./NCI-Frederick
Jean-Claude Zenklusen NCI/NIH
Li Zhang, M.D. Anderson Cancer Center